相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Barbara Bottazzi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
Sei Naito et al.
EUROPEAN UROLOGY (2010)
Inflammatory Protein Serum Amyloid A1 Marks a Subset of Conventional Renal Cell Carcinomas with Fatal Outcome
Claudia Paret et al.
EUROPEAN UROLOGY (2010)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma
T. V. Johnson et al.
JOURNAL OF UROLOGY (2010)
Systemic inflammation, nutritional status and survival in patients with cancer
Donald C. McMillan
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
Kazutaka Saito et al.
EUROPEAN UROLOGY (2009)
Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-α for Metastatic Renal Cell Carcinoma
Nobuo Shinohara et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C Score
Yasumasa Iimura et al.
JOURNAL OF UROLOGY (2009)
Preoperative Erythrocyte Sedimentation Rate Is an Independent Prognostic Factor in Japanese Patients with Localized Clear Cell Renal Cell Carcinoma
Yoshihisa Kawai et al.
UROLOGIA INTERNATIONALIS (2009)
The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer
Sara Ramsey et al.
BJU INTERNATIONAL (2008)
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy
Soichiro Yoshida et al.
BJU INTERNATIONAL (2008)
Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer
Sara Ramsey et al.
BJU INTERNATIONAL (2008)
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma
Azizbek Ramankulov et al.
CANCER LETTERS (2008)
Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
Manabu Tatokoro et al.
JOURNAL OF UROLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3
Alberto Mantovani et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
C-reactive protein, inflammatory conditions, and cardiovascular disease risk
Ravi Dhingra et al.
AMERICAN JOURNAL OF MEDICINE (2007)
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality - A European study of 313 patients
Pierre I. Karakiewicz et al.
CANCER (2007)
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically
Kazutaka Saito et al.
BJU INTERNATIONAL (2007)
Multi-institutional validation of a new renal cancer-specific survival nomogram
Pierre I. Karakiewicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer
Sara Ramsey et al.
CANCER (2007)
Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma
Yoshinobu Komai et al.
BJU INTERNATIONAL (2007)
Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma
Sang Eun Lee et al.
BJU INTERNATIONAL (2006)
Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma
Keiichi Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
U. M. Vogl et al.
BRITISH JOURNAL OF CANCER (2006)
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer
GWA Lamb et al.
BRITISH JOURNAL OF CANCER (2006)
Plasma C-reactive protein and risk of cancer: A prospective study from Greece
D Trichopoulos et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
AM Al Murri et al.
BRITISH JOURNAL OF CANCER (2006)
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma
S Sengupta et al.
CANCER (2006)
Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer
Paul Glen et al.
PANCREATOLOGY (2006)
Prognostic factors in advanced cancer patients:: Evidence-based clinical recommendations -: A study by the Steering Committee of the European Association for Palliative Care
M Maltoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder
M Hilmy et al.
BRITISH JOURNAL OF CANCER (2005)
C-reactive protein: A biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy
A Casamassima et al.
JOURNAL OF UROLOGY (2005)
Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis
MMJ Nielen et al.
ARTHRITIS AND RHEUMATISM (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: Prognostic value of interleukin-6-from the Groupe Francais d'Immunotherapie
S Negrier et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
E Bromwich et al.
BRITISH JOURNAL OF CANCER (2004)
Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter
A Agrawal et al.
MOLECULAR IMMUNOLOGY (2003)
Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma
M Oya et al.
CARCINOGENESIS (2003)
Metastatic renal carcinoma comprehensive prognostic system
J Atzpodien et al.
BRITISH JOURNAL OF CANCER (2003)
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
A Zisman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Mathematical model to predict individual survival for patients with renal cell carcinoma
A Zisman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A postoperative prognostic nomogram for renal cell carcinoma
MW Kattan et al.
JOURNAL OF UROLOGY (2001)
分享论文
